相关实验视频

Updated: Jan 8, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

通过TGF-β通路,LAMC2促进胆囊癌转移

Mengyou Xu¹, Yuanyuan Zhang^2,3, Huibo Feng¹

¹Peking University Cancer Hospital, Beijing, China.

Cancer cell international

|December 14, 2025

概括

拉米宁-γ2 (LAMC2) 通过激活TGF-β信号来促进胆囊癌 (GBC) 的进展和转移. 这一发现表明LAMC2是潜在的预后生物标志物和GBC患者的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

胆囊癌 (GBC) 是一种具有较差患者存活率的侵袭性恶性瘤.
拉米宁-γ2 (LAMC2) 涉及癌症的发展和各种癌症的化学抵抗.
在GBC进展中LAMC2的特定作用在很大程度上仍未定义.

研究的目的:

研究LAMC2在胆囊癌中的生物学作用和分子机制.
为了确定LAMC2表达是否与GBC患者的结果相关.
评估LAMC2作为潜在的预后生物标志物和GBC的治疗标.

主要方法:

用蛋白质组学和RNA-seq来评估LAMC2在GBC组织中的表达.
在体外测试 (殖民地/球体形成,伤口愈合,穿孔) 和体内转移模型评估了LAMC2的功能影响.
血清细胞器官模型和分子分析 (Western blot,RT-qPCR) 探索了潜在的机制,包括TGF-β/SMAD2信号传递.

主要成果:

在GBC组织中,LAMC2显著过度表达,与患者的不良结果相关.
沉默LAMC2抑制了GBC细胞的增殖,球体的形成和有机体的生长.
LAMC2 缺乏抑制了 GBC 转移,逆转了上皮细胞-介质细胞转变 (EMT),并涉及TGF-β/SMAD2 途径的反调节.

结论:

LAMC2促进了GBC的进展和转移,可能是通过调节TGF-β信号通路.
LAMC2代表了GBC的一个潜在的预后生物标志物.
准LAMC2可能为胆囊癌提供一种新的治疗策略.

更多相关视频

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Experimental Metastasis Assay

Experimental Metastasis Assay

Published on: August 24, 2010

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...